Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Abeona Therapeutics Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 71 | 95 | +24 |
| Shares | 29.7M | 34.9M | +5.23M (+17.6%) |
| Value | $141.2M | $198.2M | +$57.0M (+40.4%) |
New holders (42)
Institutions that held Abeona Therapeutics Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (18)
Institutions that held Abeona Therapeutics Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Rosalind Advisors, Inc. | 1,805,817 | $8.60M |
| Ikarian Capital, LLC | 533,581 | $2.54M |
| Standard Life Aberdeen plc | 224,356 | $1.07M |
| Walleye Capital LLC | 183,306 | $872.5K |
| HRT Financial LP | 96,655 | $460.0K |
| Connective Capital Management, LLC | 74,913 | $356.6K |
| Balyasny Asset Management LLC | 73,849 | $351.5K |
| Omers Administration Corp | 72,200 | $343.7K |
| Schonfeld Strategic Advisors LLC | 65,011 | $309.5K |
| Gsa Capital Partners LLP | 63,835 | $304.0K |
| Citadel Advisors LLC | 32,044 | $152.5K |
| LMR Partners LLP | 27,120 | $129.1K |
| Quantessence Capital LLC | 26,087 | $124.2K |
| ExodusPoint Capital Management, LP | 24,409 | $116.0K |
| Engineers Gate Manager LP | 20,501 | $97.6K |
| Jefferies Financial Group Inc. | 18,000 | $85.7K |
| Cannon Global Investment Management, LLC | 14,000 | $66.6K |
| Avion Wealth | 85 | $0 |